Table 2.
Multivariable logistic regression model for factors associated with accessing liver specialty care (using generalized estimating equations)
| Variable | Unadjusted OR (95% CI) | Adjusted OR (95% CI) |
|---|---|---|
| Substance abuse treatment | 1.42 (0.99–2.03) | 1.38 (0.90–2.11) |
| Female gender | 0.95 (0.53–1.7) | 0.87 (0.44–1.70) |
| Age (per 10-year increase) | 1.37 (0.95–1.97) | 1.22 (0.80–1.86) |
| Race or ethnicitya | ||
| Black vs. White | 0.77 (0.43–1.39) | 0.70 (0.36–1.36) |
| Other vs. White | 0.82 (0.44–1.52) | 0.73 (0.38–1.41) |
| Current ART receiptb | 2.50 (1.58–3.93) | 2.18 (1.33–3.59) |
| CD4 (per 100 cells/mm3 increase) | 1.12 (1.03–1.21) | 1.11 (1.02–1.20) |
| Liver disease complicationsc,d | 2.09 (1.18–3.72) | 2.15 (1.02–4.54) |
| ALT (per 40 IU/L) | 1.15 (0.98–1.35) | 1.10 (0.90–1.33) |
| Depressive symptomse | 0.87 (0.59–1.28) | 0.81 (0.51–1.27) |
| Ever had psychiatric treatment | 1.42 (0.82–2.45) | 1.21 (0.65–2.25) |
| Injection drug usec | 0.78 (0.49–1.24) | 0.84 (0.48–1.45) |
| 30-day alcohol abstinence | 1.67 (1.17–2.38) | 1.55 (1.04–2.32) |
| Alcohol dependencec,f | 0.62 (0.35–1.08) | 0.72 (0.35–1.49) |
Note. The number of observations is 620.
a
The reference group is White.
b
Highly active antiretroviral therapy.
c
In the past 6 months.
d
Any liver complications refer to jaundice, ascites, hepatic encephalopathy, esophageal varices, or gastrointestinal bleeding.
e
Using the CES-D, where ≥21 denotes depressive symptoms in chronic diseases.
f
Alcohol dependence as defined by the CIDI short form.